Browsing Tag
University of Queensland
3 posts
Atrogi’s ATR-258 breakthrough: muscle-targeted β2-agonist mimics exercise to treat obesity, diabetes, and muscle loss
Atrogi’s ATR-258 mimics exercise through skeletal muscle targeting to reduce fat and preserve muscle, redefining obesity and diabetes therapies.
June 23, 2025
Why has ovarian cancer eluded early screening success—and what’s changing now?
Ovarian cancer screening has failed for decades—now new tests like exosome and cfDNA panels are finally changing the story. Find out what’s driving the shift.
June 3, 2025
INOVIQ (ASX: IIQ) soars on breakthrough ovarian cancer test data at ASCO 2025
INOVIQ Ltd (ASX: IIQ) stock surged 47.73% after ASCO 2025 data showed 77% sensitivity, 99.6% specificity in ovarian cancer screening. Explore what's next for EXO-OC.
June 2, 2025